Vistagen Therapeutics, Inc. adopted an Executive Severance Plan effective October 7, 2026, to provide key employees with severance payments and other benefits upon resignation or termination without cause, amending the previous Change in Control Executive Severance Plan. This establishes the terms for retention following an involuntary termination.